Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Drugs|May 27, 2004
Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatmentMarkus RuhnkeCurrent Drug Targets|April 14, 2006
Epidemiology of Candida albicans infections and role of non-Candida-albicans yeastsMarkus RuhnkeEuropean Journal of Medical Research|June 19, 2002
Management of mycoses in patients with hematologic disease and cancer -- review of the literatureMarkus Ruhnke, G MaschmeyerEuropean Journal of Medical Research|April 14, 2011
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literatureG Kofla, Markus RuhnkeTherapeutic Advances in Hematology|December 2, 2016
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesMarkus Ruhnke, Stefan SchwartzJournal of Microbiological Methods|September 2, 2006
Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expressionGrzegorz Kofla, Markus RuhnkeExpert Opinion on Pharmacotherapy|June 17, 2005
Voriconazole: review of a broad spectrum triazole antifungal agentGrzegorz Kofla, Markus RuhnkeThe Lancet. Oncology|December 3, 2014
Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteriaMarkus Ruhnke, Renate Arnold, Petra GastmeierMycoses|May 11, 2011
Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapyAgata Mikolajewska, Stefan Schwartz, Markus RuhnkeCNS Drugs|July 17, 2007
CNS aspergillosis: recognition, diagnosis and managementMarkus Ruhnke, Grzegorz Kofla, Kirsten Otto, et al.Pageof 6